EP2244814
RECOMBINANT VWF FORMULATIONS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
23.12.2008EP published:
2.6.2021EP application number:
08866246.5
EPO information:
European Patent Register
Max expiry date:
22.12.2028
Title:
RECOMBINANT VWF FORMULATIONS
Timeline
Today
23.12.2008EP application
2.6.2021EP Publication
Owner
Name:
Takeda Pharmaceutical Company LimitedAddress:
1-1, Doshomachi 4-chome, Chuo-ku,, Osaka-shi, Osaka, JP
Inventor
Name:
MATTHIESSEN, PeterAddress:
1020 Vienna, AT
Name:
TURECEK, PeterAddress:
3400 Klosterneuburg, AT
Name:
SCHWARZ, Hans-PeterAddress:
1180 Vienna, AT
Name:
SCHNECKER, KurtAddress:
1170 Vienna, AT
Priority
Number:
1741807 PDate:
28.12.2007Country:
US
Number:
1788107 PDate:
31.12.2007Country:
US
Classification
Categories:
A61K 9/08, B01D 61/22, A61K 9/00, A61K 38/36, A61P 7/04